Get access

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy, safety and tolerability of cholinesterase inhibitors in dementia with Lewy Bodies, Parkinson's Disease with dementia and cognitive impairment in Parkinson's disease (considered as separate phenomena and also grouped together as LB disease).

Get access to the full text of this article